Allogeneic mesenchymal stem cell infusion therapy (ACESO-IHD)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic mesenchymal stem cell infusion therapy (ACESO-IHD), covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) [Phase 1, Phase 2]